"In order to raise chances, the number of clinical trials enter Phase II must be raised"
A position that a country takes in the new drug development field is decided based on the structure of clinical trials. While most clinical trials in the U.S. are on Phase I and Phase II, most Korean pharmaceutical companies are working on Phase I and Phase III clinical trials.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.